Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG) / A. Tomova ... [et al.].
In: Onkológia. -- ISSN 1336-8176. -- Roč. 6, č. 1 (2011), s. 56.
nádory prsníka - farmakoterapia * metastázy nádorové * cytostatiká - použitie terapeutické - toxicita * štúdie multicentrické ako téma * terapia sekvenčná * docetaxel * gemcitabín * abstrakt v angličtine